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Abstract
Hyperplasia associated with a loss of tissue homeostasis can induce DNA replication stress, leading
to precancerous dysregulation. Epidermal gd T cells reside in the primary barrier that protects against
diverse environmental insults; however, the functions of these T cells in tissue surveillance are not
completely understood. In mice with inducible Notch1 inactivation in keratinocytes that causes
epidermal hyperplasia, epidermal gd T cells sensed stressed keratinocytes and migrated into the
cutaneous draining lymph nodes. Simultaneous induction of b-galactosidase (b-Gal) as a putative
antigen expressed in the process of precancerous dysregulation and Notch1 ablation in the epidermis
resulted in elevated b-Gal-specific IgG2a production. Epidermal gd T cells were found to have the
capacity to express chemokine (C-C motif) receptor 7 and migrate into the lymph nodes. Cutaneous
draining lymph node cells in Notch1-inactivated mice expressed high levels of IFN-g upon anti-CD3
plus anti-CD28 stimulation. Furthermore, induced expression of b-Gal in mice that lacked epidermal
gd T cells failed to induce anti-b-Gal IgG. These results suggest that epidermal gd T cells play an
essential role in the initiation process of epidermal antigen-specific humoral immune responses and
demonstrate the importance of epidermal gd T cells in sensing precancerous dysregulation and
activating adaptive immunity.
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Introduction
The immune system is tightly regulated to react against in-
vaded non-self-antigens and to avoid responses against
self-antigens. T and B cells that react to self-antigens are
either eliminated or suppressed during development. Pre-
cancerous cells that express a ‘mutated-self’-antigen can
also be targets of immune responses. The essential role of
the adaptive immune response in eliminating these cells has
been demonstrated in studies on immune-deficient or re-
combination activating gene 2 (RAG-2)-deficient mice that
are more susceptible to carcinogens (1). Dormant tumors
that grow in the absence of adaptive immunity are kept in
check by the immune system (2). It is well established that
the immune system detects pathogens using pattern recog-
nition molecules that bind foreign microbes and induce in-
nate immune responses that subsequently activate adaptive
immune responses. Although T and B cells specific for tumor
cells have been found in patients with tumors (3–5), it is not
clear how innate immune responses initiate and activate an-
tigen-specific immune responses. It is important to know
how the immune system can sense precancerous changes
in cells that activate the immune response to break estab-
lished self-tolerance and prevent cancer development.
Anti-tumor immune responses are initiated by some innate
immune responses (6). Abnormal cellular proliferation leads to
genotoxic stress, which activates the DNA damage response,
leading to the recruitment of DNA repair enzymes and elevated
p53 protein levels (7). NKG2D ligands that are not expressed
on the surface of normal cells are up-regulated during geno-
toxic stress (8). Expression of NKG2D ligands, including the
Rae-1 family (a, b, c, d and e), histocompatibility 60 (H60)
and murine UL-16-binding protein-like transcript 1 in mice
and the MHC class I polypeptide-related sequence A and
UL-16 binding protein families in humans (9, 10), can play
a significant role in initiating the activation of NK cells and
some other NKG2D-expressing cells. The initiation of immune
responses may include some danger signals expressed by
stressed cells. S100 proteins comprise a multi-gene family of
low molecular weight calcium-binding proteins that can also
be induced by stimuli that cause DNA damage such as ioniz-
ing radiation and UV irradiation (11). Many members of this
gene family are encoded in the epidermal differentiation com-
plex located on chromosome 1q21 in human and 3f2 in the
mouse (12). S100A8 and S100A9 form homo- and hetero-
dimers and are related to the hyperproliferative state of the
epidermis. These proteins are often expressed in other
tumors including adenocarcinomas and prostate and breast
cancers. However, it is still unknown whether adaptive im-
mune responses against tumor-specific antigens are also acti-
vated as a consequence of the process initiated during
abnormal proliferation.
In the epidermis, there are two major populations of cells
that have differentiated from hematopoietic precursor cells.
Langerhans cells (LCs) are specialized dendritic cells (DCs)
that capture and process antigens and then present them to
T cells in the draining lymph nodes. These cells are thought
to initiate adaptive immune responses against pathogenic
organisms (13) but maintain self-tolerance by presenting
self-antigens at steady state (14). LCs have been shown to
regulate the immune response in some experimental sys-
tems since depletion of LCs augments contact hypersensi-
tivity (15). Another cell type in the epidermis is the dendritic
epidermal T cell that expresses cd TCRs. These T cells ex-
press a canonical Vc5/Vd1 TCR and are generated by posi-
tive selection in the fetal thymus and migrate to the skin.
The molecule, skint1, which is expressed both in the thymus
and epidermis, has been identified recently to select these
T cells (16). Unlike ab T cells, cd T cells recognize small
molecular weight non-peptide, stress- or tumor-induced self-
antigens (17). Other molecules recognized by murine cd
T cells include I-Ek, heat shock protein 65 and T10/22 (18).
It has been demonstrated that the induction of an NKG2D
ligand in the epidermis activates cd T cells that inhibit carci-
nogenesis (19), indicating that one of the primary functions
of epidermal cd T cells is to eliminate stressed or trans-
formed cells. cd T cells have been shown to have additional
roles in the peripheral blood, in which TCR stimulation
results in the induction of the lymph node homing receptor,
chemokine (C-C motif) receptor 7 (CCR7). These cd T cells
are found within germinal centers of B cell follicles, suggest-
ing that cd T cells play a role in humoral immunity (20). It
has also been shown that innate lymphocytes, including cd
T cells, trigger DC maturation (21). However, it is not known
whether cd T cells in the epidermis also contribute to the
induction of the adaptive immune response.
In order to address how and whether immune responses
are initiated by sensing cellular dysregulation prior to tumor
development, we used a tissue-specific model of inducible
Notch1 deletion in the epidermis, which results in hyperpro-
liferation of epidermal keratinocytes and subsequent skin tu-
mor development (22). Notch signaling in keratinocytes
results in growth suppression by inducing p21WAF1/Cip1,
which is mediated by recombination signal binding protein
for immunoglobulin kappa J region binding to the p21 pro-
moter (23). A neo-self-antigen, a putative antigen expressed
by gene mutations that may occur during cellular dysregula-
tion, was expressed using the same inducible Cre recombi-
nation system. This inducible system is desirable because
the process of precancerous changes and/or expression of
a putative antigen can be observed at a given time specifi-
cally in the epidermis. In this study, we found that deleting
Notch1 in the epidermis resulted in cellular stress, leading
to the up-regulation of p53 and S100A8 expression without
inflammatory cytokine induction. Epidermal cd T cells were
found to migrate to the cutaneous draining lymph nodes
and help B cells produce IgG specific for an epidermal anti-
gen. Epidermal cd T cells appeared to have a unique ability
to sense stressed keratinocytes and migrate to the draining
lymph nodes where they activated B cells to contribute to
the induction of adaptive immune response.
Methods
Animals
C57BL/6 mice were obtained from Sankyo Laboratories
(Shizuoka, Japan). keratin 14 (K14)-CreERT2 mice (24, 25)
were crossed with mice carrying a floxed Notch1 allele (26)
and with mice carrying the CAG-CAT-Z transgene [(27), gift
from Miyazaki]. Cre recombinase was activated by injecting
4-hydroxytamoxifen (OHT, Sigma, St Louis, MO, USA) dis-
solved in ethanol and then suspended in sunflower oil as de-
scribed previously (28). Eight- to 12-week old mice were
injected with 1 mg of OHT intra-peritoneally for 3 consecu-
tive days. Ovalbumin (OVA)-specific OT-I (29) and OT-II (30)
TCR transgenic mice were gifts from T. Tokuhisa and
H. Kishimoto, respectively. RAG2/ mice were housed in the
Research Institute for Biological Sciences, Tokyo University of
Science. TCRa/ mice were a gift from T. Nakayama. All
mice were backcrossed more than eight times onto the
C57BL/6 background and housed under specific pathogen-
free conditions. All experiments were performed in accor-
dance with protocols approved by the Animal Care and Use
Committee of the Tokyo University of Science.
Preparation of epidermal cell suspensions
Epidermal sheets were prepared from ears that were split in-
to dorsal and ventral sides and floated dermal side down for
1 h at 37C in 0.2% trypsin (Gibco BRL, Grand Island, NY,
USA) or shaved body wall skins treated with dispase II
(Roche) and DNase (Sigma) as described previously (31)
for western blot analysis. The epidermis was peeled off and
the cells were suspended by mixing and pipetting the iso-
lated epidermal sheets.
Antigen presentation assay
CD4+ T cells were purified from spleen cells obtained from
OVA-specific OT-II TCR transgenic mice using anti-CD4
magnetic-activated cell sorting (MACS) beads (Miltenyi Bio-
tec, Auburn, CA, USA). Cells were carboxy fluorescein diace-
tate succinimidyl ester (CFSE)-labeled and total epidermal
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cells were used to present OVA323–339 peptides. To ana-
lyze cross-presentation to CD8+ OT-I T cells, CD8+ T cells
were purified from OVA-specific OT-I splenocytes with anti-
CD8 MACS beads. Epidermal cells were incubated for 6 h
with 1 mg ml1 OVA and then washed and transferred into
fresh medium. On day 3 of culture, LCs were enriched by
HISTOPAQUE-1083 (Sigma) and purified with anti-CD11c
magnetic beads (Miltenyi Biotec). Varying numbers of
LCs were used to present OVA to OT-I CD8+ T cells and 3H-
thymidine incorporation was measured.
Flow cytometry
Single-cell suspensions of epidermal cells or cutaneous drain-
ing lymph node cells were stained with primary antibodies fol-
lowed by PE–Cy5–streptavidin or PE–Cy7–streptavidin. The
following mAbs were used for multi-parameter flow cytometric
analysis: FITC-, Allophycocyanin (APC)- or PE-conjugated
anti-TCRcd (e-Bioscience, San Diego. CA. USA), biotin-
conjugated anti-CD3 (e-Bioscience), PE-conjugated anti-TCRb
(e-Bioscience), biotin-conjugated anti-NKG2D (e-Bioscience),
FITC-conjugated anti-I-A (e-Bioscience), PE-conjugated anti-
B220, PE-conjugated anti-CD11c (e-Bioscience), FITC-conju-
gated anti-mouse Vc5 (BD Pharmingen, San Diego, CA, USA),
APC-conjugated anti-CCR7 (BioLegend) and FITC- or PE–
Cy5-conjugated anti-CD25 (e-Bioscience).
Histochemistry and immunoblotting
For hematoxylin and eosin (H&E) and b-galactosidase
(b-Gal) histochemistry, 10-lm-thick frozen sections were cut
with a cryostat (Leica) and then stained with X-gal
(5 bromo-4-chloro-3-indolyl b-D-galactosidase) as described
previously (32). Whole-cell protein extracts were prepared
from epidermal cells and used for immunoblotting. Antibodies
against Notch1 (sc-6041; Santa Cruz, Santa Cruz, CA, USA),
mouse K5 (Covance, Princetone, NJ, USA) or a-tubulin
(sc-5286, Santa Cruz) were used as probes. HRP-conjugated
anti-goat or anti-mouse IgG was used as a second antibody.
Analysis of anti-b-Gal antibodies
Blood samples from the indicated mice were collected.
ELISA plates were coated overnight with 50 ng b-Gal protein
per well and then blocked with Assay Diluent (BD Bioscien-
ces). Serial dilutions of sera were adsorbed on the coated
plates for 1 h. Bound antibody was detected with anti-mouse
IgG (CHEMICON), anti-mouse IgG1 (BETHYL, Montgomery,
TX, USA), anti-mouse IgG2a (BETHYL) or anti-mouse IgG2b
(Southern Biotech, Birmingham, AL, USA).
Real-time reverse transcription–PCR
Total RNA was isolated from epidermal cell suspensions us-
ing RNeasy Fibrouse Tissue Midi Kits (Qiagen) or lymph
node cells using Isogen (Wako, Osaka, Japan). Complemen-
tary DNA was prepared by reverse transcription using 1 lg
RNA. Quantitative real-time PCR was performed with the
Smart Cycler II System using SYBR Green Master Mix
(TAKARA, Shiga, Japan). Values for each gene were normal-
ized to the expression levels of hypoxanthine guanine phos-
phoribosyl transferase (HPRT) messenger RNA (mRNA). All
samples were run in triplicate. The specific primers used for
PCR were as follows—HPRT: 5#-TTGTTGTTGGATATGCCCT-
TGACTA-3#, 5#-AGGCAGATGGCCACAGGACTA-3#; IL-1a:
5#-AAGTTTGTCATGAATGATTCCCTC-3#, 5#-GTCTCACTAC-
CTGTGATGAGT-3#; tumor necrosis factor (TNF-a): 5#-CATC-
TTCTCAAAATTCGAGTGACAA-3#, 5#-TGGGAGTAGACAAG-
GTACAACCC-3#; S100A8: 5#-GGAAATCACCATGCCCTCTA-
3#, 5#-GCTGTCTTTGTGAGATGCCA-3#; S100A9: 5#-CCTGA-
CACCCTGAGCAAGAAG-3#, 5#-CTTATCATTTCCCAGAAC-
AA-3#; IL-6: 5#-CCACTTCACAAGTCGGAGGCTTA-3#, 5#-
GCAAGTGCATCATCGTTGTTCATAC-3#, IL-4: 5#-TCTCGAAT-
GTACCAGGAGCCATATC-3#, 5#-AGCACCTTGGAAGCCCTA-
CAGA-3#; IFN-c: 5#-ATGAACGCTACACACTGCATCTT-3#, 5#-
GAATCAGCAGCGACTCCTTTTCC-3#; Vc5-Jc1: 5#-GCACTG-
GATCCAACTGAAAGAAG-3#, 5#-CAGAGGGAATTACTATGA-
GCTTAG-3#.
Contact hypersensitivity responses
To induce allergic contact dermatitis, mice were sensitized
on day 0 by an epicutaneous application of 25 ll of 0.5%
2,4 dinitrofluorobenzene (DNFB, Sigma) in acetone:olive oil
(4:1) to shaved abdominal skin. On day 5, baseline ear
thickness was measured with an engineer’s micrometer, after
which the mice were challenged with 10 ll of 0.2% DNFB
on both sides of one ear. Ears were measured 24 h after
challenge and data were expressed as the ear swelling re-
sponse above baseline (i.e. ear thickness 24 h after chal-
lenge minus baseline ear thickness).
Chemotaxis assay
Transmigration assays were performed using 24-well trans-
well chambers with a 5-lm-pore filter (Corning Costar, NY,
USA). The epidermal cell suspension was placed on a filter
at 1 3 106 per well and then incubated for 48 h at 37C.
The cells that transmigrated into the lower chambers con-
taining either medium alone or chemokine (C-C motif) ligand
21 (CCL21) were recovered and analyzed by flow cytometry.
Antibodies against CCL21 (R&D Systems) were used to
block the migration.
Results
Inactivation of Notch1 in the epidermis results in
stress-induced gene expression
Epidermal basal cells proliferate to maintain epidermal ho-
meostasis. Ablation of Notch1 in epidermal cells results in
derepressed b-catenin signaling, which leads to hyperplasia
(22). In order to determine if the tissue surveillance system
can sense precancerous changes, ligand-dependent Cre re-
combination was used to mutate a specific gene at a given
time (24, 25). CreERT2 driven by the K14 promoter enables
the Lox-flanked Notch1 gene to be excised in the epidermis
upon administration of OHT. K14-CreERT2 (Cre) mice and
those carrying Notch1loxlox alleles (Cre/Notch1loxlox) were
injected with OHT intraperitonealy for 3 consecutive days. On
day 9, which was 1 week post-treatment, the epidermis was
isolated from the abdominal and back skin, and Notch1 ex-
pression was analyzed. As shown in Fig. 1(A), Notch1 was
detected as an intact 300 kDa protein and as a cleaved
120 kDa band in control mice, while both bands were virtually
lost in Cre/Notch1loxlox mice. These Notch1-deleted epidermal
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cells had a selective growth advantage and differed from nor-
mal proliferating keratinocytes because p53, which is induced
by cellular stress, was up-regulated in Notch1-deleted
(Notch1/) epidermal cells (Fig. 1B). Chemically induced
skin carcinogenesis is often correlated with sustained inflam-
mation during tumor development. To determine if keratino-
cyte hyperproliferation caused by Notch1 inactivation also
up-regulated inflammatory mediators, the epidermis was iso-
lated from both control and Notch1-inactivated mice 1 week
after OHT administration and mRNA levels were measured by
real-time PCR. The expression of S100A8, which is known to
be up-regulated during skin carcinogenesis (33), was in-
creased >10-fold. Another S100 protein, S100A9, was also
slightly up-regulated in the Notch1-deleted epidermis
(Fig. 1C). In addition, levels of the inflammatory cytokines
TNF-a, IL-1a and IL-6 were the same as in the control, sug-
gesting that the Notch1 inactivation-mediated skin disorder
differed from normal proliferation and was distinct from inflam-
mation caused by chemicals and pathogens.
Deletion of Notch1 enhances immune responses against
a neo-self-antigen induced in the epidermis
During the course of tumor development when mutations of
various genes are involved, a mutated gene product can
Fig. 1. Notch1 inactivation in keratinocytes induces cellular stress. K14-Cre-ERT2 (lane 1: Cre) and K14-Cre-ERT2/Notch1loxlox (lane 2: Cre/
Notch1lox/lox) were analyzed by immunoblotting and the same membrane was re-blotted with anti-keratin 5. Arrows indicate the 300 and 120 kDa
(cleaved) bands. (B) Induction of p53 was analyzed in epidermal cells isolated from control (lane 1) and Notch1-inactivated (lane 2: Notch1/)
mice 1 week after OHT injection. Total cell lysates extracted from several Notch1/ mice had similar expression levels. A representative blot is
shown. (C) Epidermal cell suspensions were prepared from control and K14-Cre-ERT2/Notch1lox/lox (Notch1/) mice 1 week after treatment. Total
RNA was extracted from epidermal cells. Real-time reverse transcription–PCR was performed with primers for the indicated genes and the
results were normalized to HPRT mRNA levels. Relative expression levels of each gene in oil-injected (open columns) and OHT-injected (closed
columns) mice are shown. Data are representative of three independent experiments. Error bars indicate standard deviation. ND = not detected.
NS = not significant.
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become a neo-self-antigen. Since we were interested in deter-
mining whether such an antigen expressed prior to tumor de-
velopment could be a target of immune responses, the same
inducible Cre recombination system was used to induce the
expression of a putative antigen in the epidermis. We first
tested whether ectopic induction of a neo-self-antigen in the
epidermis could lead to antigen-specific immune responses.
Cre-mediated recombination using K14-CreERT2 was per-
formed for the CAG-CAT-Z transgene (27), where the CAT
gene within the loxP sites was excised upon Cre recombina-
tion, resulting in b-Gal expression in the epidermis 2 days af-
ter OHT administration (Fig. 2A). Although the epidermis with
induced b-Gal expression became slightly thicker in 2 weeks,
no mononuclear cells infiltrated into the epidermis for up to
17 weeks (Fig. 2B). LCs in the epidermis are known to cap-
ture antigens and migrate into the draining lymph nodes
where they present these antigens to T cells. However, there
was no sign of b-Gal-specific T cell activation in the draining
lymph nodes as lymph node cells obtained 2 weeks after
OHT administration did not express cytokines (IL-2, IL-4 and
IFN-c) upon b-Gal stimulation (data not shown). Interestingly,
although b-Gal-specific T cell responses were not detected,
b-Gal-specific IgG production was induced within 1 week af-
ter OHT administration and increased until 3 weeks (Fig. 2C).
These results indicated that a newly synthesized antigen in
keratinocytes induced antigen-specific immune responses,
but the responses were transient and mice induced to ex-
press b-Gal (b-Gal+) did not develop any dermatitis.
We next constructed a model in which expression of
a neo-self-antigen and aberrant proliferation were induced
as a consequence of gene mutations during tumor develop-
ment. Deletion of Notch1 and expression of b-Gal occurred
simultaneously upon OHT administration in K14-CreERT2/
CAG-CAT-Z/Notch1lox/lox mice. In mice induced to express
b-Gal and delete Notch1, external changes such as hair loss
on the ventral skin were frequently observed 2 weeks after
OHT administration. Similar but minor changes were some-
times observed in Notch1-deleted (Notch1/) mice; how-
ever, mice with Notch1 deletion plus b-Gal expression
(b-Gal+/Notch1/) had a severe phenotype (Fig. 3A). H&E
staining of skin sections from b-Gal+/Notch1/ mice
revealed epidermal hyperplasia containing epidermal cell
layers with flat shapes, indicating that there were dramatic
responses in the b-Gal+/Notch1/ epidermis (Fig. 3B). How-
ever, a single mutation, either inactivating Notch1 or
expressing b-Gal, was not sufficient to induce these
responses. In addition, the serum levels of anti-b-Gal IgG in
b-Gal+/Notch1/ mice were much higher than those in
b-Gal+ mice (Fig. 3C). Among the anti-b-Gal IgG isotypes,
levels of IgG2a were significantly elevated in b-Gal+/
Notch1/ mice, while those of IgG1, which was a dominant
isotype after b-Gal immunization and b-Gal induction in the
epidermis, were even lower in Notch1-deleted mice
(Fig. 3D). Cutaneous draining lymph node cells obtained
from b-Gal+ and b-Gal+/Notch1/ mice 2 weeks after OHT
administration were stimulated with either b-Gal or anti-CD3
plus anti-CD28 antibodies. IFN-c expression was elevated in
b-Gal+/Notch1/ mice stimulated with anti-CD3 plus anti-
CD28 but not with b-Gal (Fig. 3E). IL-4 expression was poor
in both b-Gal+ and b-Gal+/Notch1/ mice. These results
suggested that the high IgG2a levels in b-Gal+/Notch1/
mice were due to the elevated levels of IFN-c produced by
T cells but possibly not by b-Gal-specific CD4+ T cells.
Enhanced immune responses in the Notch1-inactivated
epidermis are LC independent
LCs play an important role in presenting epidermal antigens
in the draining lymph nodes. To determine whether the high
IgG production was due to the functional activation of LCs,
the ability of LCs to present antigens was analyzed. OVA
was pulsed on epidermal cells isolated from both Notch1/
and control mice and the proliferation of CFSE-labeled CD4+
T cells purified from OVA-specific TCR transgenic mice
(OT-II) was measured. As shown in Fig. 4(A), OVA-specific
T cells responded to both control and Notch1/ APC simi-
larly. LCs are also known to cross-present antigens derived
from the skin (13). Therefore, epidermal cells were pulsed
with OVA protein, and LCs purified from epidermal cell cul-
tures were tested for their ability to activate CD8+ T cells
obtained from OVA-specific TCR transgenic mice (OT-I).
Again, we did not find any differences in the ability of control
and Notch1/ to cross-present antigens (Fig. 4B). Contact
Fig. 2. Induced expression of b-Gal in keratinocytes leads to anti-b-Gal IgG production. (A) X-Gal staining of skin sections isolated from K14-Cre-
ERT2 (Cre) and K14-Cre-ERT2/CAG-CAT-Z (Cre/b-Gal) mice administered with OHT. (B) Sections of Cre and Cre/b-Gal back skin obtained 2 and
17 weeks after OHT administration were stained with H&E. Scale bar, 100 lm. (C) Serum IgG levels specific for b-Gal in Cre/b-Gal mice with or
without OHT administration were analyzed. Data represent the means 6 SDs and are representative of five independent experiments.
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hypersensitivity is a classical skin response in which LCs are
considered to play a role. Notch1-deleted and control mice
were sensitized with DNFB and swelling associated with the
response after DNFB challenge to the ears was measured.
Although the ears of Notch1-deleted mice were slightly
thicker because of epidermal hyperplasia, DNFB-specific
changes in Notch1-deleted and control mice were in the
same range (Fig. 4C). In addition, migration of LCs in
Notch1/ mice was normal (data not shown). These results
suggested that LCs were not functionally altered by Notch1
inactivation to augment anti-b-Gal T cell responses and in-
duce antibody production in b-Gal+/Notch1/ mice.
Fig. 3. Simultaneous induction of b-Gal expression and Notch1 ablation leads to skin disorder and augmentation of anti-b-Gal IgG. (A) The
indicated set of mice was analyzed 2 weeks after OHT administration. One representative analysis out of three independent experiments is
shown. (B) Sections of the ventral part of the skin obtained from individual mice are shown (H&E stain). Scale bar, 100 lm. (C) Cre (closed
circles), b-Gal+ (open diamonds), b-Gal+/Notch1/ (closed triangles) mice injected with OHT and wild-type control mice immunized with b-Gal
(b-Gal immunization, a line with cross symbols) were analyzed. Serum levels of anti-b-Gal IgG were measured by ELISA. One representative
analysis out of three independent experiments is shown. Mean values 6 SDs of triplicate assays are shown. (D) Anti-b-Gal IgG isotypes were
further determined from the same serum samples analyzed in (C). Mean values of triplicate analyses are shown (mean 6 SD). (E) Inguinal and
axillary lymph node cells obtained from b-Gal+ and b-Gal+/Notch1/ mice were cultured either with anti-CD3 plus anti-CD28 or b-Gal. The
expression of IFN-c or IL-4 was analyzed by real-time reverse transcription–PCR (mean 6 SD). Data from one representative assay out of three
independent experiments are shown. ND = not detected. *, P < 0.05 (Student’s t-test).
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Activation of epidermal cd T cells results in the induction of
a lymph node homing program
We next examined whether epidermal cd T cells are involved
in b-Gal-specific IgG production. A previous report showed
that cd T cells can interact with B cells and induce Ig class
switching (34). In this study, the percentages of epidermal
cd T cells expressing Vc5 were decreased in the Notch1-
inactivated epidermis, which was in contrast to the infiltration
of Vc5 T cells (Fig. 5A). The ratio of Vc5+ cells in the draining
lymph nodes was analyzed by measuring mRNA levels of rear-
ranged Vc5-Jc1. It was found that Vc5 expression in the drain-
ing lymph nodes was increased significantly in Notch1/
mice (Fig. 5B). Increased numbers of Vc5+ cells in TCRcd+,
TCRb, B220 and CD11c cells were also found in the
draining lymph nodes in Notch1/ mice (Fig. 5C). These
results suggested that epidermal cd T cells expressing Vc5
were activated and migrated into the draining lymph nodes.
Since epidermal cd T cells recognize unknown antigens
expressed in stressed keratinocytes (17), epidermal cell sus-
pensions were cultured in vitro in the presence or absence of
an artificial stimulus, ionomycin, to determine whether cd
T cells can express the lymph node homing receptor, CCR7.
TCRcd expression levels in cultured cells were lower than
those in freshly isolated cells, which might be due to TCRcd
engagement. Cultured epidermal cells contained cd T cells
expressing both CCR7 and CD25, and ionomycin stimulation
increased the number of those cells (Fig. 5D). To determine
whether CCR7 expressed in epidermal cd T cells is functional,
we examined the chemotaxis of epidermal cells in response
to the chemokine CCL21. An epidermal cell suspension was
placed in a transwell chamber and cells that migrated out of
the chamber were analyzed by FACS. The number of cells re-
covered in the bottom chamber containing CCL21 was much
higher (Fig. 5E) and those cells responding to CCL21 con-
tained both I-A+ LCs and cd T cells. TCRcd+ cells were in
a fraction of small cells, expressing lower levels of TCRcd than
freshly isolated cells. Similar results were obtained by stimulat-
ing cd T cells with anti-TCRcd antibodies. Vc5+ cells were
found in the population of small cells migrated in response to
CCL21 (Supplementary Figure 1A, available at International
Immunology Online), and the migration of Vc5+ cells was
blocked by adding anti-CCL21 antibodies (Supplementary
Figure 1B, available at International Immunology Online). I-A+
cells, however, expressed higher levels of I-A molecules and
were distributed mostly in a large cell population (Fig. 5F).
These results suggested that cd T cells became mobile in re-
sponse to factors expressed by stressed keratinocytes and
were targeted to draining lymph nodes expressing CCL21.
The molecules expressed by stressed keratinocytes that
activate cd T cells have not been identified. It was consid-
ered that abnormal keratinocyte proliferation might have in-
duced DNA damage responses because the DNA damage
checkpoint gene p53 was already expressed in this early
precancerous stage (Fig. 1B). In these cells, however,
NKG2D ligands that are induced as a result of DNA damage
in keratinocytes (19) were not detected in the Notch1-
inactivated epidermis (data not shown). Therefore, cd T cell
activation in the Notch1-inactivated epidermis did not seem
to be mediated by the NKG2D receptor.
Fig. 4. LCs are not functionally altered in Notch1-inactivated mice.
(A) Epidermal cell suspensions were prepared from wild-type
(control) and Notch1-inactivated (Notch1/) mice 2 weeks after
OHT administration. OVA-specific CD4+ T cells isolated from OT-II
mice were labeled with CFSE and cultured with epidermal cells in the
presence of OVA peptide. Data are representative of three in-
dependent experiments. (B) CD11c-positive cells were purified from
epidermal cell suspensions that had been pulsed with OVA for 6 h
and cultured for 2 days. OVA-specific CD8+ T cells isolated from OT-I
mice were incubated with increasing numbers of CD11c+ cells, and
3H-thymidine incorporation was measured after 2 days. Data are
representative of three independent experiments. (C) Mice were
treated with OHT 2 weeks before DNFB sensitization. Contact
hypersensitivity responses were measured 24 h after the challenge.
Control (n = 6) and induced Notch1/ (n = 6) mice are shown (mean
values are indicated by bars).
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Activation of B cells to produce IgG specific for an epidermal
antigen
Epidermal cd T cells migrated in the draining lymph nodes
might activate B cells directly or in collaboration with other
antigen presenting cells. In order to determine whether epi-
dermal cd T cells are required for b-Gal-specific IgG produc-
tion, we reconstituted Cre/b-Gal/RAG2/ mice with normal
spleen cells. These mice lack epidermal cd T cells because
they are generated during early ontogeny (Fig. 6A); however,
peripheral lymphocytes are restored by the transferred sple-
nocytes (Fig. 6B). OHT administration in the reconstituted
mice did not induce anti-b-Gal IgG production, although
Cre/b-Gal mice injected with OHT produced anti-b-Gal IgG
(Fig. 6C). Since control RAG2/ mice reconstituted with
the same number of B6 splenocytes produced reasonable
levels of anti-b-Gal IgG after immunization, the defect in IgG
production in Cre/b-Gal/RAG2/ mice after OHT administra-
tion could be due to the absence of epidermal cd T cells. In
order to determine whether b-Gal-specific IgG is produced
in the absence of normal ab T cells, Cre/b-Gal/TCRa/ mice
were also tested for their ability to produce anti-b-Gal IgG.
b-Gal-specific IgG was produced in Cre/b-Gal/TCRa/ mice
after OHT administration, although the levels were low
(Fig. 6C). These results suggested that cd T cells played an
essential role at least in the initiation of IgG production
against the antigen expressed in the epidermis. Switching
to IgG, however, was mainly performed by conventional
T cells. It seemed that only when cd T cells were highly acti-
vated or a large number of cd T cells moved to the lymph
nodes by sensing abnormal epidermal dysregulation, cd
T cells induced high levels of IgG, especially IgG2a, against
newly expressed epidermal antigens (Fig. 3D). It is also possi-
ble that the activated cd T cells interacted with B cells non-
specifically. Indeed, we found higher levels of serum IgG in
Notch1/ mice 6–8 months after Notch1 ablation (data not
shown). However, further analysis is required to determine
whether the activation of cd T cells in response to epidermal
dysregulation causes autoimmune responses.
Discussion
The prevention of tumor development by tissue tumor immu-
nosurveillance is of great importance. However, most studies
have analyzed immune responses against established tumor
cells. In an attempt to examine the initiation process of the
immune response, a tissue-specific inducible gene-targeting
approach was used. In this study, we investigated whether
the immune system can sense precancerous dysregulation
in the epidermis induced by Notch1 ablation. Interestingly,
epidermal cd T cells migrated into the cutaneous draining
lymph nodes, indicating that epidermal dysregulation
caused by a gene mutation prior to tumor development
could be sensed by immunosurveillance. In addition, a neo-
self-antigen, which is a putative model antigen expressed
upon dysregulation, was presented to B cells and antigen-
specific IgG production was augmented.
cd T cells sensed the dysregulation of keratinocytes as
early as 1 week after OHT treatment. It was previously shown
that up-regulation of Rae-1, an NKG2D ligand, in the epider-
mis induced cd T cell activation and ab T cell infiltration (35).
Notch1 inactivation in keratinocytes might have induced
NKG2D ligand expression as aberrant keratinocyte prolifera-
tion may cause DNA damage responses. In our system, al-
though the expression of neither the NKG2D ligand Rae-1
nor H60 was detected in this early stage, it is possible that
different types of NKG2D ligands may have been expressed.
As p53 was up-regulated in the Notch1-inactivated epidermis,
keratinocytes were already affected and expressed some
stress-related factors. S100A8 expression was significantly
up-regulated in the Notch1-inactivated epidermis, which
could indicate aberrant proliferation and cell stress. S100A8
can be induced with various stimuli, including UV irradiation
and ionizing radiation. Phorbol myristate acetate (PMA), a tu-
mor-promoting chemical, also up-regulates S100A8 and
S100A9 (33) and induces inflammatory factors (36). In the
Notch1-deleted epidermis, however, expression levels of in-
flammatory cytokines such as TNF-a and IL-6 were not ele-
vated. These factors are released from keratinocytes and
promote inflammation, which is also linked to tumor develop-
ment (37). Primary keratinocytes treated with PMA express
TNF-a, IL-6, granulocyte macrophage colony-stimulating fac-
tor and S100A8; however, the induction of these genes, ex-
cept S100A8, depends on nuclear factor jB activation (38),
suggesting that the precancerous state induced by Notch1
ablation is distinct from the classical inflammation-associated
tumor model. It is still unknown what molecules expressed by
stressed keratinocytes activated epidermal cd T cells in this
model, and future studies will attempt to identify these factors.
Epidermal LCs capture antigens in the skin and migrate to
the cutaneous lymph nodes, where they present antigens to
Fig. 5. Migration of cd T cells into the lymph nodes is promoted in the Notch1-inactivated epidermis. (A) An epidermal cell suspension was
prepared from control and Notch1-inactivated mice 1 week after induction and analyzed by FACS. CD45+ hematopoietic cells were gated and
the percentage of each population was calculated. Values are means 6 SDs of three independent experiments. *, P < 0.05 (Student’s t-test).
(B) Expression of rearranged Vc5 in cutaneous draining lymph node cells was analyzed by real-time quantitative reverse transcription–PCR.
Results were normalized to HPRT mRNA levels. Results represent the means of triplicate samples 6 SD. One representative data out of three
independent experiments are shown. Age-matched wild-type mice injected with OHT were used as a control. (C) Cutaneous draining lymph node
cells were obtained 1 week after induction and stained with antibodies against TCRcd, B220, TCRb, CD11c and Vc5. TCRcd+ cells in B220,
TCRb and CD11c cells were gated and Vc5+ cells were analyzed. (D) Epidermal cells, either freshly isolated or cultured for 48 h in the
presence or absence of 0.5 lM ionomycin, were stained with antibodies against CCR7, CD25 and TCRcd and analyzed by FACS. Dead cells
were removed by Ficoll-Paque centrifugation, TCRcd+ cells were gated and analyzed for CD25 and CCR7 expression. One representative
analysis out of four independent experiments is shown. (E) Epidermal cells (1 3 107 ml1) were put into a transwell chamber (100 ll) that was
placed in a well filled with 600 ll medium with or without 100 nM CCL21. After 48 h, the cells that had migrated out of the chamber were counted.
Results represent mean 6 SD. (n = 4) (F) TCRcd and I-A expression on freshly isolated epidermal cells and cells that had migrated into the
CCL21-containing medium is shown. Migrated cells contained small and large cell populations, which were gated on separately. Data in (C, D
and F) are representative of four independent experiments.
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T cells. At steady state, however, dendritic cells are usually
tolerogenic when they present antigens (14). Similarly, in our
model in which b-Gal expression was induced in keratino-
cytes upon OHT administration, b-Gal-specific T cell
responses were not detected even though b-Gal was a non-
self-antigen in these mice. One explanation why these mice
were tolerant to b-Gal might be because b-Gal was likely
expressed in the thymus after OHT administration, as the
K14 promoter that drives Cre-ERT2 is active in thymic epithe-
lial cells. However, it has been shown that mice expressing
both an antigen driven by the K14 promoter and a TCR rec-
ognizing the antigen develop severe autoimmune disease
(39), suggesting that tolerance to b-Gal expressed under
the control of the K14 promoter might not be induced in the
thymus. Moreover, self-antigen-specific CD8+ T cells are acti-
vated by LCs at steady state when antigen-specific CD8+
T cells are transferred into recipient mice that express the
antigen in keratinocytes (40), which argues against the in-
duction of tolerance by LCs at steady state. However, anti-
gen-specific T cell activation in the normal repertoire of
naive T cells and not in T cells obtained from TCR transgenic
mice may require additional signals to overcome regulatory
mechanisms, although LCs have a mature DC phenotype
and express CD80/86 in the lymph nodes. In b-Gal+/
Notch1/ mice, which have dysregulated epidermal cells
even though stronger responses in the ventral part of
the skin were observed, LCs seemed to remain tolerogenic.
The lack of inflammatory cytokines, such as TNF-a, could
be the main reason why LCs did not activate b-Gal-specific
T cell responses.
Fig. 6. Requirement of cd T cells for anti-b-Gal IgG production. (A) Epidermal cells from wild-type mice, RAG2/ and RAG2/ mice that had
received 1 3 108 wild-type splenocytes (RAG2/ reconstituted) were stained with anti-I-A or anti-TCRcd together with anti-CD45 as a marker of
hematopoietic cells. (B) Cutaneous draining lymph node cells from the same mice analyzed in (A) were stained with anti-B220 and anti-CD3, and
CD3+ cells were further analyzed for CD4 and CD8 expression. (C) RAG2/ mice and mice carrying the K14-Cre-ERT2/CAG-CAT-Z transgenes
(Cre/b-Gal/RAG2/) were reconstituted with 1 3 108 wild-type splenocytes. Two weeks later, Cre/b-Gal, reconstituted Cre/b-Gal/RAG2/ and
Cre/b-Gal/TCRa/ mice were injected with OHT. As a control, RAG2/ mice reconstituted with splenocytes were immunized with b-Gal. Serum
levels of anti-b-Gal IgG were analyzed 3 weeks after induction. Data from a representative analysis out of three independent experiments are
shown.
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An interesting finding in this study was that IgG specific
for b-Gal induced in keratinocytes was produced in the ab-
sence of obvious b-Gal-specific T cell activation. This result
suggested that a newly expressed antigen in the epidermis
was immunogenic and could induce IgG production. At
steady state, there were some cd T cells expressing Vc5 in
the cutaneous draining lymph nodes of normal mice. It is
not clear whether these cells homed from the thymus or mi-
grated out of the epidermis. However, since these cells dis-
played an activated phenotype, they are likely not naive
cells. In the experiment inducing b-Gal in TCRa/ mice,
anti-b-Gal IgG was produced although the levels were much
lower than those in wild-type b-Gal+ mice. We consider that
some cd T cells traffic from the epidermis to the cutaneous
draining lymph nodes at steady state and that these cd
T cells contribute to IgG production against epidermal
antigens. This idea was supported by the experiment using
RAG2/ mice reconstituted with splenocytes. These mice
have no epidermal cd T cells and failed to produce anti-
b-Gal IgG. This suggests that during a keratinocyte emer-
gency, cd T cells in the epidermis are activated and
extensively migrate into the lymph nodes, leading to en-
hanced production of IgG specific for the epidermal antigen.
Stimulation of cutaneous draining lymph node cells in vitro
with anti-CD3 plus anti-CD28 from b-Gal-expressing mice
induces prompt expression of IFN-c, which was much higher
in b-Gal+/Notch1/ than in b-Gal+ mice. There were more
Vc5+cd T cells in the lymph nodes in Notch1/ mice, sug-
gesting that cd T cells that migrated from the epidermis se-
creted IFN-c that induced class switching to IgG2a. In fact,
b-Gal induction together with Notch1 deletion resulted in
high levels of b-Gal-specific IgG2a. In mice induced only to
express b-Gal, IgG1 levels were higher than IgG2a levels
among the anti-b-Gal isotypes, suggesting that there was
also some conventional T cell help although we could not
detect b-Gal-specific T cell activation. It is still not clear
whether cd T cells could augment only the production of IgG
specific for neo-antigens, as they may not discriminate self-
and non-self-antigens. We suspected that the total IgG2a
levels in Notch1-inactivated mice were also elevated after
the induction. However, although total IgG levels were high,
we did not find elevated IgG2a levels (data not shown). It
is therefore possible that cd T cell activation after Notch1 de-
letion was transient and that these cells were only involved in
the initiation process. In addition, self-reactive B cells are
usually suppressed by another regulatory mechanism.
The involvement of cd Tcells in B cell class switching was pre-
viously shown (41, 42). TCRa/ mice infected with a vaccinia
virus expressing the vesicular stomatitis virus (VSV) glyco-
protein were able to induce VSV-specific IgG class switching
(34). As has been shown in human peripheral cd T cells (20),
the lymph node homing receptor CCR7 was induced in epider-
mal cd T cells upon activation in vitro. Human cd T cells are
also able to function as professional APC and can be induced
to express MHC class II molecules (43). It is possible that mu-
rine cd T cells could also capture antigens in the epidermis
and carry them into the draining lymph nodes. Alternatively,
b-Gal expressed in keratinocytes was taken up by LCs and
brought to the draining lymph nodes, and co-migrating cd
T cells helped to induce b-Gal-specific B cell activation.
In tumor immunosurveillance, both innate and adaptive im-
munity help to prevent tumor development. Activation of cd
T cells that express NKG2D have been shown to suppress
a cutaneous malignancy in the epithelia (19). In the Notch1-
inactivated epidermis, stress-related molecules expressed
by dysregulated keratinocytes initiated cd T cell activation.
These activated cd T cells migrated into the draining lymph
nodes and mediated the induction of adaptive immune
responses. It is not clear whether antibodies against the anti-
gen expressed in precancerous cells can target to kill them.
In our model, antigen-specific T cell responses, which are
thought to play a central role in tumor immunosurveillance,
did not seem to be activated. The sporadic tumor model that
expresses an immunogenic antigen induces antigen-specific
T cells and antigen-specific IgG production (44); however,
tolerance is induced in T cells by tumor cells. In the precan-
cerous state, however, tolerance may not be induced yet. It
will be interesting to determine whether antigen-specific
T cells are activated by inducing additional inflammatory sig-
nals, which were not observed in the Notch1-deleted dysre-
gulated epidermis. Furthermore, the transition from the
precancerous state to tumor development may alter T cell re-
sponsiveness. Since tumor formation in Notch1-inactivated
mice was very slow, we are now establishing a model to in-
duce the expression of a constitutively active oncogene in
addition to Notch1 inactivation, where tumor formation
occurs rapidly. These mice will further elucidate the roles of
cd T cells and other T cells in preventing tumor development.
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